ATE494010T1 - Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung - Google Patents
Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendungInfo
- Publication number
- ATE494010T1 ATE494010T1 AT03716207T AT03716207T ATE494010T1 AT E494010 T1 ATE494010 T1 AT E494010T1 AT 03716207 T AT03716207 T AT 03716207T AT 03716207 T AT03716207 T AT 03716207T AT E494010 T1 ATE494010 T1 AT E494010T1
- Authority
- AT
- Austria
- Prior art keywords
- materials
- production
- methods
- therapeutic delivery
- delivery compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000000463 material Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 239000002184 metal Substances 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 229910021645 metal ion Inorganic materials 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Macromonomer-Based Addition Polymer (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36035002P | 2002-02-27 | 2002-02-27 | |
| PCT/US2003/005937 WO2003072143A1 (en) | 2002-02-27 | 2003-02-27 | Compositions for delivery of therapeutics and other materials, and methods of making and using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE494010T1 true ATE494010T1 (de) | 2011-01-15 |
Family
ID=27766225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03716207T ATE494010T1 (de) | 2002-02-27 | 2003-02-27 | Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7138105B2 (de) |
| EP (1) | EP1478406B1 (de) |
| JP (1) | JP2005524657A (de) |
| AT (1) | ATE494010T1 (de) |
| AU (1) | AU2003219922B2 (de) |
| CA (1) | CA2476589C (de) |
| DE (1) | DE60335608D1 (de) |
| WO (1) | WO2003072143A1 (de) |
Families Citing this family (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040220100A1 (en) * | 2000-07-21 | 2004-11-04 | Essentia Biosystems, Inc. | Multi-component biological transport systems |
| US20030194798A1 (en) * | 2001-05-24 | 2003-10-16 | Surber Mark W. | Minicell compositions and methods |
| KR20040091076A (ko) * | 2002-02-26 | 2004-10-27 | 아마토 세이야쿠 가부시키가이샤 | 리포솜에의 금속착체의 봉입방법 |
| US7635463B2 (en) * | 2002-02-27 | 2009-12-22 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials |
| US20100069293A1 (en) * | 2002-02-27 | 2010-03-18 | Pharmain Corporation | Polymeric carrier compositions for delivery of active agents, methods of making and using the same |
| WO2003072143A1 (en) | 2002-02-27 | 2003-09-04 | Pharmain, Ltd. | Compositions for delivery of therapeutics and other materials, and methods of making and using the same |
| US7629049B2 (en) * | 2002-10-18 | 2009-12-08 | Medasorb, Inc. | Hemocompatible polymer systems and related devices |
| WO2005010080A1 (ja) * | 2003-07-28 | 2005-02-03 | Teijin Limited | 温度応答性ハイドロゲル |
| JP2007500027A (ja) * | 2003-07-30 | 2007-01-11 | アンタイス エス．エイ． | 生物医学的な使用のための複合マトリックス |
| PL1663186T3 (pl) * | 2003-09-10 | 2007-11-30 | Cristalia Produtos Quim Farmaceuticos Ltda | Stabilna kompozycja farmaceutyczna związku fluoroeterowego do stosowania w znieczuleniu, sposób stabilizowania związku fluoroeterowego, zastosowanie środka stabilizującego do zapobiegania degradacji związku fluoroeterowego |
| US8193291B2 (en) * | 2004-02-23 | 2012-06-05 | Caiteng Zhang | Solution of metal-polymer chelate(s) and applications thereof |
| CA2558676C (en) | 2004-03-03 | 2019-04-16 | Essentia Biosystems, Inc. | Compositions and methods for topical diagnostic and therapeutic transport |
| US9211248B2 (en) | 2004-03-03 | 2015-12-15 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| CN1946431B (zh) * | 2004-03-03 | 2011-12-07 | 雷文斯治疗公司 | 用于肉毒毒素的局部施用和透皮递送的组合物和方法 |
| WO2005112977A2 (en) * | 2004-04-23 | 2005-12-01 | Pharmain, Ltd. | Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
| BRPI0404983A (pt) * | 2004-09-03 | 2006-05-02 | Nanocore Biotecnologia Ltda | composições imunogênicas |
| EP1846042A2 (de) * | 2005-01-05 | 2007-10-24 | Board of Regents, The University of Texas System | Konjugate zur doppelten abbildung und radiochemotherapie: zusammensetzung sowie herstellung und anwendungen davon |
| US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
| US20090291508A1 (en) * | 2008-05-20 | 2009-11-26 | Rapid Pathogen Screening Inc. | Nanoparticles in diagnostic tests |
| SG160357A1 (en) * | 2005-03-03 | 2010-04-29 | Revance Therapeutics Inc | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| DE502006007526D1 (de) * | 2005-09-09 | 2010-09-09 | Aesculap Ag | Antimikrobielles medizintechnisches produkt, verfahren zu seiner herstellung und verwendung |
| JP4670583B2 (ja) * | 2005-10-20 | 2011-04-13 | チッソ株式会社 | 水溶性カチオン性磁気微粒子を用いた脂質ベシクルの分離又は検出方法 |
| EP1971371B1 (de) | 2005-12-01 | 2015-08-05 | Pronai Therapeutics, Inc. | Krebstherapien und dabei verwendete pharmazeutische zusammensetzungen |
| KR101529318B1 (ko) | 2005-12-19 | 2015-06-16 | 파마인 코포레이션 | 치료제를 전달하기 위한 소수성 코어 담체 조성물, 이조성물의 제조 방법 및 그 조성물의 이용 방법 |
| EP2049081B1 (de) | 2006-08-09 | 2012-11-14 | Intarcia Therapeutics, Inc. | Osmotische freisetzungssysteme und kolbenanordnungen |
| US9604196B2 (en) | 2006-11-20 | 2017-03-28 | Cytosorbent, Inc. | Size-selective hemocompatible polymer system |
| CA2669887A1 (en) * | 2006-11-21 | 2008-05-29 | Viamet Pharmaceuticals, Inc. | Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties |
| US20100004124A1 (en) * | 2006-12-05 | 2010-01-07 | David Taft | Systems and methods for delivery of materials for agriculture and aquaculture |
| US20090246155A1 (en) * | 2006-12-05 | 2009-10-01 | Landec Corporation | Compositions and methods for personal care |
| US20090263346A1 (en) * | 2006-12-05 | 2009-10-22 | David Taft | Systems and methods for delivery of drugs |
| US8956602B2 (en) * | 2006-12-05 | 2015-02-17 | Landec, Inc. | Delivery of drugs |
| US8399007B2 (en) * | 2006-12-05 | 2013-03-19 | Landec Corporation | Method for formulating a controlled-release pharmaceutical formulation |
| WO2008128058A1 (en) * | 2007-04-13 | 2008-10-23 | The Trustees Of The University Of Pennsylvania | New gallium bisaminothiolate complexes for myocardial imaging |
| HRP20130259T1 (hr) | 2007-04-23 | 2013-04-30 | Intarcia Therapeutics, Inc. | Suspenzijske formulacije inzulinotropnih peptida i njihove uporabe |
| US8252302B2 (en) * | 2007-06-11 | 2012-08-28 | Edge Therapeutics, Inc. | Methods and compositions to treat hemorrhagic conditions of the brain |
| US10092524B2 (en) | 2008-06-11 | 2018-10-09 | Edge Therapeutics, Inc. | Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage |
| US7960336B2 (en) * | 2007-08-03 | 2011-06-14 | Pharmain Corporation | Composition for long-acting peptide analogs |
| US8563527B2 (en) | 2007-08-20 | 2013-10-22 | Pharmain Corporation | Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same |
| WO2009079066A2 (en) * | 2007-09-26 | 2009-06-25 | Aparna Biosciences | Therapeutic and vaccine polyelectrolyte nanoparticle compositions |
| US8114883B2 (en) * | 2007-12-04 | 2012-02-14 | Landec Corporation | Polymer formulations for delivery of bioactive materials |
| US20090176892A1 (en) * | 2008-01-09 | 2009-07-09 | Pharmain Corporation | Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same |
| DK2240155T3 (da) | 2008-02-13 | 2012-09-17 | Intarcia Therapeutics Inc | Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler |
| WO2009114520A2 (en) * | 2008-03-10 | 2009-09-17 | Pharmain Corporation | Compositions for treatment with metallopeptidases, methods of making and using the same |
| KR101760953B1 (ko) * | 2008-09-04 | 2017-07-24 | 아밀린 파마슈티칼스, 엘엘씨. | 비-수성 담체를 이용한 서방성 제형물 |
| CA2773737C (en) * | 2009-09-09 | 2021-11-16 | Pharmain Corporation | Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same |
| SMT201700583T1 (it) | 2009-09-28 | 2018-01-11 | Intarcia Therapeutics Inc | Instaurazione e/o terminazione rapida di erogazione di farmaci in modo sostanzialmente stazionario |
| DK2343051T3 (da) | 2010-01-05 | 2014-10-27 | Nat Univ Dong Hwa | Anti-cancer formulering |
| US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
| HK1198933A1 (en) | 2011-04-05 | 2015-06-19 | Edge Therapeutics | Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow |
| US8785569B2 (en) * | 2011-11-22 | 2014-07-22 | Original Biomedicals Co., Ltd. | Drug carrier with chelating complex micelles and the application thereof |
| BR112015010220A2 (pt) | 2012-11-05 | 2017-12-05 | Pronai Therapeutics Inc | métodos de utilização de biomarcadores para tratamento de câncer |
| JP6564369B2 (ja) | 2013-12-09 | 2019-08-21 | デュレクト コーポレイション | 薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法 |
| CA2951243A1 (en) | 2014-09-24 | 2016-03-31 | Colgate-Palmolive Company | Bioavailability of metal ions |
| US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| US10925639B2 (en) | 2015-06-03 | 2021-02-23 | Intarcia Therapeutics, Inc. | Implant placement and removal systems |
| CN105054074A (zh) * | 2015-07-01 | 2015-11-18 | 浙江海洋学院 | 一种鱼糜酶解肽亚铁螯合物抗氧化微胶囊及其制备工艺 |
| CA3001329A1 (en) * | 2015-10-09 | 2017-04-13 | Frantz Le Devedec | Crosslinked degradable particles.and methods of producing the same |
| RU2760007C2 (ru) | 2016-05-16 | 2021-11-22 | Интарсия Терапьютикс, Инк. | Полипептиды, селективные к рецепторам глюкагона, и способы их применения |
| USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
| USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
| CN110225762A (zh) | 2017-01-03 | 2019-09-10 | 因塔西亚制药公司 | 包括glp-1受体激动剂的连续施用和药物的共同施用的方法 |
| US11905377B2 (en) | 2019-01-17 | 2024-02-20 | Pendant Biosciences, Inc. | Factors controlling drug release in cross-linked poly(valerolactone) based matrices |
| JP2022537337A (ja) * | 2019-06-18 | 2022-08-25 | マックス－プランク－ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | 金属錯体試薬を介するＨｉｓタグ付タンパク質などの標的分子への標識および／または担体の部位特異的、速度論的に不活性なコンジュゲーション |
| JP2023525544A (ja) * | 2020-05-12 | 2023-06-16 | ビーエーエスエフ ソシエタス・ヨーロピア | 分散剤としてのリジンのカルボキシメチル化ポリマーの使用及びそれを含む組成物 |
| WO2025207519A1 (en) * | 2024-03-23 | 2025-10-02 | Texas Tech University System | Biocompatible and biodegradable polymer nanodiscs as lipoprotein-mimicking nanocarriers with high stability and long circulation time for drug delivery |
Family Cites Families (115)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5614492A (en) * | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
| US5120712A (en) * | 1986-05-05 | 1992-06-09 | The General Hospital Corporation | Insulinotropic hormone |
| US7138486B2 (en) | 1986-05-05 | 2006-11-21 | The General Hospital Corporation | Insulinotropic hormone derivatives and uses thereof |
| US6849708B1 (en) * | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof |
| US5118666A (en) * | 1986-05-05 | 1992-06-02 | The General Hospital Corporation | Insulinotropic hormone |
| US5527524A (en) * | 1986-08-18 | 1996-06-18 | The Dow Chemical Company | Dense star polymer conjugates |
| US4857311A (en) | 1987-07-31 | 1989-08-15 | Massachusetts Institute Of Technology | Polyanhydrides with improved hydrolytic degradation properties |
| US5681543A (en) * | 1988-02-29 | 1997-10-28 | Shering Aktiengesellschaft | Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI |
| US5776894A (en) * | 1988-12-05 | 1998-07-07 | Novartis Ag | Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors |
| US5744166A (en) * | 1989-02-25 | 1998-04-28 | Danbiosyst Uk Limited | Drug delivery compositions |
| US5554388A (en) * | 1989-02-25 | 1996-09-10 | Danbiosyst Uk Limited | Systemic drug delivery compositions comprising a polycationi substance |
| US5542935A (en) | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
| EP0610441A4 (de) * | 1991-10-29 | 1996-01-10 | Clover Cons Ltd | Vernetzbare polysacchariden, polykationen und lipiden verwendbar zum einkapseln und abgabe von arzneimitteln. |
| US5770563A (en) * | 1991-12-06 | 1998-06-23 | The United States Of America As Represented By The Department Of Health And Human Services | Heparin- and sulfatide binding peptides from the type I repeats of human thrombospondin and conjugates thereof |
| US6113946A (en) * | 1992-04-03 | 2000-09-05 | The Regents Of The University Of California | Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| DK0636028T3 (da) * | 1992-04-03 | 2004-07-12 | Univ California | Selvorganiserende polynucleotidleveringssystem omfattende et amfipatisk kationisk peptid |
| ES2199226T3 (es) * | 1992-09-04 | 2004-02-16 | The General Hospital Corporation | Polimeros biocompatibles que contienen mitades diagnosticas o terapeuticas. |
| US5871710A (en) | 1992-09-04 | 1999-02-16 | The General Hospital Corporation | Graft co-polymer adducts of platinum (II) compounds |
| US5395619A (en) | 1993-03-03 | 1995-03-07 | Liposome Technology, Inc. | Lipid-polymer conjugates and liposomes |
| US6284727B1 (en) * | 1993-04-07 | 2001-09-04 | Scios, Inc. | Prolonged delivery of peptides |
| US5605672A (en) | 1993-06-09 | 1997-02-25 | The General Hospital Corporation | Blood pool imaging composition and method of its use |
| US5763585A (en) | 1993-10-13 | 1998-06-09 | Anergen, Inc. | Method of making MHC-peptide complexes using metal chelate affinity chromatography |
| FI955320A7 (fi) * | 1994-03-07 | 1995-11-24 | Univ Michigan | Bioaktiivisia ja/tai kohdennettuja dendriimikonjugaatteja |
| EP0804249A2 (de) * | 1994-03-15 | 1997-11-05 | Brown University Research Foundation | Polymeres system zur freisetzung von genen |
| US5466467A (en) | 1994-03-30 | 1995-11-14 | The United States Of America As Represented By The Secretary Of The Navy | Liposomes containing polymerized lipids for non-covalent immobilization of proteins and enzymes |
| GB9409496D0 (en) * | 1994-05-12 | 1994-06-29 | London Health Ass | Method for improving glycaemic control in diabetes |
| US20010006943A1 (en) * | 1994-12-23 | 2001-07-05 | Ejvind Jensen | Protracted GLP-1 compositions |
| US5834428A (en) * | 1995-04-14 | 1998-11-10 | 1149336 Ontario Inc. | Glucagon-like peptide-2 and its therapeutic use |
| US5929031A (en) * | 1995-05-02 | 1999-07-27 | Baxter Biotech Technology Sarl | Storage stable hemoglobin solutions |
| US5855610A (en) | 1995-05-19 | 1999-01-05 | Children's Medical Center Corporation | Engineering of strong, pliable tissues |
| US6521211B1 (en) * | 1995-06-07 | 2003-02-18 | Bristol-Myers Squibb Medical Imaging, Inc. | Methods of imaging and treatment with targeted compositions |
| US5891418A (en) | 1995-06-07 | 1999-04-06 | Rhomed Incorporated | Peptide-metal ion pharmaceutical constructs and applications |
| JPH11507697A (ja) | 1995-06-09 | 1999-07-06 | エヌ． ドロハン，ウィリアム | キチンヒドロゲル、それらの製造方法及び利用 |
| MY147327A (en) * | 1995-06-29 | 2012-11-30 | Novartis Ag | Somatostatin peptides |
| US5942253A (en) | 1995-10-12 | 1999-08-24 | Immunex Corporation | Prolonged release of GM-CSF |
| EP0856026A1 (de) | 1995-10-19 | 1998-08-05 | Receptagen Corporation | Polyethylenglycolen mit diskreter länge |
| DE69735057T2 (de) * | 1996-03-12 | 2006-08-31 | PG-TXL Co., L.P., Houston | Wasserlösliche paclitaxel-prodrogen |
| US6254854B1 (en) | 1996-05-24 | 2001-07-03 | The Penn Research Foundation | Porous particles for deep lung delivery |
| US6277819B1 (en) * | 1996-08-30 | 2001-08-21 | Eli Lilly And Company | Use of GLP-1 or analogs in treatment of myocardial infarction |
| US6006753A (en) | 1996-08-30 | 1999-12-28 | Eli Lilly And Company | Use of GLP-1 or analogs to abolish catabolic changes after surgery |
| US7235627B2 (en) * | 1996-08-30 | 2007-06-26 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
| UA65549C2 (uk) * | 1996-11-05 | 2004-04-15 | Елі Ліллі Енд Компані | Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція |
| JPH10158195A (ja) | 1996-11-28 | 1998-06-16 | Res Inst For Prod Dev | 配位結合を利用した薬物−高分子複合体製剤の調製方法 |
| US6458373B1 (en) | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| US6120751A (en) | 1997-03-21 | 2000-09-19 | Imarx Pharmaceutical Corp. | Charged lipids and uses for the same |
| NZ502358A (en) * | 1997-07-18 | 2002-11-26 | Infimed Therapeutics Inc | Hydrogel composition comprising a biologically active substance combined with a macromer |
| DE19740069A1 (de) * | 1997-09-12 | 1999-03-18 | Clariant Gmbh | Mischungen von langkettigen Phosphorsäurealkylestern |
| US6468532B1 (en) * | 1998-01-22 | 2002-10-22 | Genentech, Inc. | Methods of treating inflammatory diseases with anti-IL-8 antibody fragment-polymer conjugates |
| US6703359B1 (en) * | 1998-02-13 | 2004-03-09 | Amylin Pharmaceuticals, Inc. | Inotropic and diuretic effects of exendin and GLP-1 |
| US6998387B1 (en) * | 1998-03-19 | 2006-02-14 | Amylin Pharmaceuticals, Inc. | Human appetite control by glucagon-like peptide receptor binding compounds |
| US6509323B1 (en) | 1998-07-01 | 2003-01-21 | California Institute Of Technology | Linear cyclodextrin copolymers |
| ATE445006T1 (de) * | 1998-08-10 | 2009-10-15 | Us Gov Health & Human Serv | Differenzierung von nicht-insulin in insulin- produzierende zellen durch glp-1 und exendin-4 und dessen verwendung |
| CA2340118C (en) | 1998-08-12 | 2009-01-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient |
| US6284725B1 (en) * | 1998-10-08 | 2001-09-04 | Bionebraska, Inc. | Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue |
| CA2358463A1 (en) * | 1999-01-08 | 2000-07-13 | Virginia Commonwealth University | Polymeric delivery agents and delivery agent compounds |
| US6365173B1 (en) * | 1999-01-14 | 2002-04-02 | Efrat Biopolymers Ltd. | Stereocomplex polymeric carriers for drug delivery |
| IL138990A0 (en) | 1999-02-12 | 2001-11-25 | Biostream Inc | Matrices for drug delivery and methods for making and using the same |
| ATE419528T1 (de) * | 1999-04-28 | 2009-01-15 | Eidgenoess Tech Hochschule | Polyionische beschichtungen für analytische und sensor-vorrichtungen |
| WO2001028569A1 (en) | 1999-10-15 | 2001-04-26 | Canji, Inc. | Targeted vectors |
| US6569832B1 (en) * | 1999-11-12 | 2003-05-27 | Novo Nordisk A/S | Inhibition of beta cell degeneration |
| US6593308B2 (en) * | 1999-12-03 | 2003-07-15 | The Regents Of The University Of California | Targeted drug delivery with a hyaluronan ligand |
| MXPA02009031A (es) * | 2000-03-14 | 2004-08-19 | Amylin Pharmaceuticals Inc | Efectos del peptido-1(7-36) tipo glucagon en la motilidad antro-piloro.duodenal. |
| US6998137B2 (en) * | 2000-04-07 | 2006-02-14 | Macromed, Inc. | Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| US6589549B2 (en) * | 2000-04-27 | 2003-07-08 | Macromed, Incorporated | Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles |
| IL152804A0 (en) | 2000-05-16 | 2003-06-24 | Bolder Biotechnology Inc | Methods for refolding proteins containing free cysteine residues |
| ATE397938T1 (de) * | 2000-05-19 | 2008-07-15 | Amylin Pharmaceuticals Inc | Behandlung des akuten koronaren syndroms mit glp- 1 |
| US6338859B1 (en) | 2000-06-29 | 2002-01-15 | Labopharm Inc. | Polymeric micelle compositions |
| EP1301213B1 (de) | 2000-07-21 | 2017-01-18 | ReVance Therapeutics, Inc. | Mehrkomponentensysteme zur transport von biologischen wirkstoffen |
| US20040092432A1 (en) * | 2000-08-24 | 2004-05-13 | Thomas Jefferson University | Peptide compositions with effects on cerebral health |
| US6521736B2 (en) | 2000-09-15 | 2003-02-18 | University Of Massachusetts | Amphiphilic polymeric materials |
| WO2002034285A2 (en) * | 2000-10-20 | 2002-05-02 | Coolidge Thomas R | Treatment of hibernating myocardium and diabetic cardiomyopathy with a glp-1 peptide |
| US20020132254A1 (en) * | 2000-11-30 | 2002-09-19 | Twu Jesse J. | Molecular labeling and assay systems using poly (amino acid)-metal ion complexes as linkers |
| US7259233B2 (en) * | 2000-12-13 | 2007-08-21 | Eli Lilly And Company | Chronic treatment regimen using glucagon-like insulinotropic peptides |
| EP1351984A2 (de) * | 2000-12-13 | 2003-10-15 | Eli Lilly And Company | Amidiertes glucagonähnliches peptid-1 |
| ITMI20011057A1 (it) * | 2001-05-22 | 2002-11-22 | Bracco Imaging Spa | Preparazione ed uso di peptidi ciclici e ramificati e loro deriati marcati come agenti terapeutici agonisti o antagonisti della colecistochi |
| US7144863B2 (en) | 2001-06-01 | 2006-12-05 | Eli Lilly And Company | GLP-1 formulations with protracted time action |
| AU2002316811A1 (en) * | 2001-06-28 | 2003-03-03 | Novo Nordisk A/S | Stable formulation of modified glp-1 |
| US6586524B2 (en) * | 2001-07-19 | 2003-07-01 | Expression Genetics, Inc. | Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier |
| CA2458371A1 (en) * | 2001-08-23 | 2003-03-06 | Eli Lilly And Company | Glucagon-like peptide-1 analogs |
| US20040235726A1 (en) * | 2001-10-01 | 2004-11-25 | Jakubowski Joseph Anthony | Glucagon-like peptides (glp-1) and treatment of respiratory distress |
| US7041646B2 (en) * | 2001-10-05 | 2006-05-09 | Bayer Pharmaceuticals Corporation | Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists |
| IL161446A0 (en) * | 2001-11-26 | 2004-09-27 | Daiichi Suntory Pharma Co Ltd | Medicinal compositions for nasal absorption |
| CN1332711C (zh) * | 2002-02-20 | 2007-08-22 | 埃米球科技有限公司 | 施用glp－1分子的方法 |
| WO2003072143A1 (en) | 2002-02-27 | 2003-09-04 | Pharmain, Ltd. | Compositions for delivery of therapeutics and other materials, and methods of making and using the same |
| US7635463B2 (en) * | 2002-02-27 | 2009-12-22 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials |
| EP1525219B1 (de) * | 2002-07-04 | 2009-05-27 | Zealand Pharma A/S | Glp-1 und behandlungsmethode für diabetes |
| JP2006501820A (ja) | 2002-09-06 | 2006-01-19 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | 修飾ｇｌｐ−１受容体アゴニストおよびそれらの薬理学的使用法 |
| US7790681B2 (en) | 2002-12-17 | 2010-09-07 | Amylin Pharmaceuticals, Inc. | Treatment of cardiac arrhythmias with GLP-1 receptor ligands |
| US20040209803A1 (en) * | 2002-12-19 | 2004-10-21 | Alain Baron | Compositions for the treatment and prevention of nephropathy |
| DE602004015755D1 (de) * | 2003-03-31 | 2008-09-25 | Alza Corp | Nicht wässrige einphasige visköse vehikel und formulierungen die diese vehikel verwenden |
| EP1631308B1 (de) * | 2003-05-30 | 2013-07-31 | Amylin Pharmaceuticals, LLC | Neue verfahren und zusammensetzungen für die verbesserte transmukosale abgabe von peptiden und proteinen |
| EP2292253A3 (de) * | 2003-06-03 | 2011-12-14 | Novo Nordisk A/S | Stabilisierte Pharmazeutische Peptidzusammensetzugen |
| ATE541582T1 (de) * | 2003-06-03 | 2012-02-15 | Novo Nordisk As | Stabilisierte pharmazeutische glp-1 peptid zusammensetzungen |
| US20060247167A1 (en) * | 2003-09-01 | 2006-11-02 | Novo Nordisk A/S | Stable formulations of peptides |
| US7521527B2 (en) * | 2003-12-16 | 2009-04-21 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | GLP-1 pharmaceutical compositions |
| WO2005084180A2 (en) | 2003-12-19 | 2005-09-15 | University Of Cincinnati | Polyamides and polyamide complexes for delivery of oligonucleotide decoys |
| US20060286129A1 (en) | 2003-12-19 | 2006-12-21 | Emisphere Technologies, Inc. | Oral GLP-1 formulations |
| US20050143303A1 (en) * | 2003-12-26 | 2005-06-30 | Nastech Pharmaceutical Company Inc. | Intranasal administration of glucose-regulating peptides |
| US20060074025A1 (en) * | 2003-12-26 | 2006-04-06 | Nastech Pharmaceutical Company Inc. | Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability |
| CA2558676C (en) * | 2004-03-03 | 2019-04-16 | Essentia Biosystems, Inc. | Compositions and methods for topical diagnostic and therapeutic transport |
| FR2867679B1 (fr) * | 2004-03-17 | 2008-08-22 | Oreal | Composition cosmetiques comprenant des polyamines modifiees et utilisations desdites compositions. |
| BRPI0510093B8 (pt) * | 2004-04-20 | 2022-12-27 | Dendritic Nanotechnologies Inc | polímeros dendríticos |
| US7985424B2 (en) | 2004-04-20 | 2011-07-26 | Dendritic Nanotechnologies Inc. | Dendritic polymers with enhanced amplification and interior functionality |
| WO2005112977A2 (en) * | 2004-04-23 | 2005-12-01 | Pharmain, Ltd. | Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
| JP2008512350A (ja) | 2004-07-01 | 2008-04-24 | イェール ユニバーシティ | 標的化され、そして高密度で薬物が負荷されるポリマー性物質 |
| WO2006014425A1 (en) * | 2004-07-02 | 2006-02-09 | Biovalve Technologies, Inc. | Methods and devices for delivering glp-1 and uses thereof |
| BRPI0513508B1 (pt) * | 2004-07-19 | 2021-06-01 | Biocon Limited | Conjugados de insulina-oligômero, formulações e usos desses |
| US7285529B2 (en) * | 2005-02-28 | 2007-10-23 | Gene Tools, Llc | Embedder compositions and methods for detecting and killing cells in acidic areas of tumors |
| WO2007024899A2 (en) | 2005-08-23 | 2007-03-01 | The General Hospital Corporation | Use of glp-1, glp-1 derivatives or glp-1 fragments for skin regeneration, stimulation of hair growth, or treatment of diabetes |
| US20100041612A1 (en) | 2005-09-08 | 2010-02-18 | Martin Beinborn | Fragments of the Glucagon-Like Peptide-1 and Uses Thereof |
| AU2006308511B2 (en) | 2005-10-25 | 2013-06-13 | Starpharma Pty Limited | Macromolecular compounds having controlled stoichiometry |
| ES2586236T3 (es) | 2005-11-04 | 2016-10-13 | Glaxosmithkline Llc | Procedimientos para administrar agentes hipoglucémicos |
| KR101529318B1 (ko) * | 2005-12-19 | 2015-06-16 | 파마인 코포레이션 | 치료제를 전달하기 위한 소수성 코어 담체 조성물, 이조성물의 제조 방법 및 그 조성물의 이용 방법 |
| CN104524596B (zh) | 2006-01-20 | 2018-10-09 | 星药股份有限公司 | 经修饰的大分子 |
| US8563527B2 (en) * | 2007-08-20 | 2013-10-22 | Pharmain Corporation | Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same |
-
2003
- 2003-02-27 WO PCT/US2003/005937 patent/WO2003072143A1/en not_active Ceased
- 2003-02-27 DE DE60335608T patent/DE60335608D1/de not_active Expired - Lifetime
- 2003-02-27 EP EP03716207A patent/EP1478406B1/de not_active Expired - Lifetime
- 2003-02-27 CA CA2476589A patent/CA2476589C/en not_active Expired - Lifetime
- 2003-02-27 US US10/378,100 patent/US7138105B2/en not_active Expired - Lifetime
- 2003-02-27 JP JP2003570887A patent/JP2005524657A/ja active Pending
- 2003-02-27 AU AU2003219922A patent/AU2003219922B2/en not_active Expired
- 2003-02-27 AT AT03716207T patent/ATE494010T1/de not_active IP Right Cessation
-
2006
- 2006-07-05 US US11/428,803 patent/US7790140B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1478406B1 (de) | 2011-01-05 |
| DE60335608D1 (de) | 2011-02-17 |
| EP1478406A1 (de) | 2004-11-24 |
| US7138105B2 (en) | 2006-11-21 |
| WO2003072143A9 (en) | 2004-03-04 |
| AU2003219922B2 (en) | 2009-09-10 |
| WO2003072143A1 (en) | 2003-09-04 |
| CA2476589A1 (en) | 2003-09-04 |
| US20060239924A1 (en) | 2006-10-26 |
| AU2003219922A1 (en) | 2003-09-09 |
| CA2476589C (en) | 2014-02-25 |
| JP2005524657A (ja) | 2005-08-18 |
| US7790140B2 (en) | 2010-09-07 |
| EP1478406A4 (de) | 2006-01-11 |
| US20030224974A1 (en) | 2003-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE494010T1 (de) | Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung | |
| DE60021729D1 (de) | Photosensibilisatoren enthaltende antimikrobielle zusammensetzung, gegenstände und verfahren zur verwendung | |
| DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
| DE602005018043D1 (de) | Liposomale formulierungen mit dihydrosphingomyelin und verfahren zu ihrer verwendung | |
| ATE547101T1 (de) | Verfahren zur verwendung von diketopiperazinen und zusammensetzungen, die diese enthalten | |
| DE69933945D1 (de) | Polymer, verfahren zu seiner herstellung und zusammensetzung | |
| WO2004006906A3 (en) | Methods for the treatment of neoplasms | |
| PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
| ATE549996T1 (de) | Verfahren zur herstellung von chitosan- wundauflagen | |
| DE60043229D1 (de) | Zusammensetzung zur gefässbeschichtung | |
| GB0307834D0 (en) | Composition | |
| DE69939475D1 (de) | Blockpolymerzusammensetzung, verfahren zu dessen herstellung und druckempfindliche klebstoffzusammensetzung | |
| DE60218524D1 (de) | Verfahren zur herstellung von wasserlöslichen methacrylpolymeren, wasserlösliche methacrylpolymere und deren verwendung | |
| DE69834522D1 (de) | Hochmolekulares Flockungsmittel, Verfahren zu dessen Herstellung und Verfahren zur Wasserbehandlung mit diesem Mittel | |
| SG150559A1 (en) | Antineoplastic combinations of cci-779 and rituximab | |
| ATE520781T1 (de) | Verfahren zur veränderung des gehalts von speicherstoffen in pflanzen | |
| UA88463C2 (ru) | Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции | |
| DE60136826D1 (de) | Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs | |
| AU2003251787A1 (en) | Polymerized and modified rapamycins and their use in coating medical prostheses | |
| DE50014532D1 (de) | Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz | |
| DE60225449D1 (de) | Wildlederartiges kunstleder und verfahren zu dessen herstellung | |
| DE60206931D1 (de) | Polyetherpolymer, verfahren zu seiner herstellung, zusammensetzung für polymerfestelektrolyt und verwendung davon | |
| DE60041418D1 (de) | Zusammensetzung für hydrogele, hydrogel und dessen verwendung | |
| DE60131121D1 (de) | Wasserlösliches Copolymer, Verfahren zu dessen Herstellung und dessen Verwendung | |
| DE69918984D1 (de) | Stärkeabbau/pfropfpolymerisation : zusammensetzung, verfahren und verwendungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |